These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15753005)

  • 1. Bioprospecting in plants for engineered proteins.
    Joshi L; Lopez LC
    Curr Opin Plant Biol; 2005 Apr; 8(2):223-6. PubMed ID: 15753005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranslational modification of therapeutic proteins in plants.
    Gomord V; Faye L
    Curr Opin Plant Biol; 2004 Apr; 7(2):171-81. PubMed ID: 15003218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational modification of plant-made foreign proteins; glycosylation and beyond.
    Webster DE; Thomas MC
    Biotechnol Adv; 2012; 30(2):410-8. PubMed ID: 21839159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharming and transgenic plants.
    Liénard D; Sourrouille C; Gomord V; Faye L
    Biotechnol Annu Rev; 2007; 13():115-47. PubMed ID: 17875476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins.
    Brooks SA
    Expert Rev Proteomics; 2006 Jun; 3(3):345-59. PubMed ID: 16771706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyco-engineering in plants to produce human-like N-glycan structures.
    Castilho A; Steinkellner H
    Biotechnol J; 2012 Sep; 7(9):1088-98. PubMed ID: 22890723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant cell cultures for the production of recombinant proteins.
    Hellwig S; Drossard J; Twyman RM; Fischer R
    Nat Biotechnol; 2004 Nov; 22(11):1415-22. PubMed ID: 15529167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical production in plants: problems, solutions and opportunities.
    Gomord V; Chamberlain P; Jefferis R; Faye L
    Trends Biotechnol; 2005 Nov; 23(11):559-65. PubMed ID: 16168504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein modifications in the plant secretory pathway: current status and practical implications in molecular pharming.
    Faye L; Boulaflous A; Benchabane M; Gomord V; Michaud D
    Vaccine; 2005 Mar; 23(15):1770-8. PubMed ID: 15734039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.
    Gerngross TU
    Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody engineering and modification technologies.
    Filpula D
    Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality assessment of recombinant proteins produced in plants.
    Medrano G; Dolan MC; Condori J; Radin DN; Cramer CL
    Methods Mol Biol; 2012; 824():535-64. PubMed ID: 22160919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-translational modifications in the context of therapeutic proteins.
    Walsh G; Jefferis R
    Nat Biotechnol; 2006 Oct; 24(10):1241-52. PubMed ID: 17033665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral vectors for the expression of proteins in plants.
    Gleba Y; Klimyuk V; Marillonnet S
    Curr Opin Biotechnol; 2007 Apr; 18(2):134-41. PubMed ID: 17368018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of heterologous proteins in plants: strategies for optimal expression.
    Desai PN; Shrivastava N; Padh H
    Biotechnol Adv; 2010; 28(4):427-35. PubMed ID: 20152894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant glycans: friend or foe in vaccine development?
    Bosch D; Schots A
    Expert Rev Vaccines; 2010 Aug; 9(8):835-42. PubMed ID: 20673008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody processing and engineering in plants, and new strategies for vaccine production.
    Ma JK; Drake PM; Chargelegue D; Obregon P; Prada A
    Vaccine; 2005 Mar; 23(15):1814-8. PubMed ID: 15734047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.